Background In March 2016, one of our hospital pharmacies started using a robotic solution for chemotherapy compounding. This solution was placed in a production room with an EU-GMP class D classification. During an audit related to the start-up, our governing body requested to see results to determine if the robotic solution could uphold the EU-GMP classification for its respective areas, and sustain the same level of microbiological cleanliness as manual production done in an isolator.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with LB
Contact LB, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack